WHO

WHO announces new Director General

Tedros Adhanom Ghebreyesus has been appointed as World Health Organization (WHO) Director General after receiving a clear majority of the votes from WHO Member States. He will take office on July 1st, 2017. Upon hearing the news, ISN President David Harris stated: ‘I strongly welcome the new Director General and I look forward to a...

ISN contributes to WHO stakeholder consultation on tackling NCDs

In September 2016, ISN was invited to participate to a World Health Organisation (WHO) stakeholder consultation on the revision of Appendix 3 of the WHO NCD Global Action Plan 2013-2020. In the consultation response, ISN stressed the importance of kidney disease as a ’neglected’ disease, which raises important public health concerns worldwide and should be...

ISN participates in high-level WHO meeting in Copenhagen

Last week, ISN joined European health ministers and high-level representatives from 53 Member States at the 66th session of the World Health Organization (WHO) Regional Committee for Europe to discuss the challenges of tackling the burden of non-communicable diseases (NCDs) in Europe. At the meeting, ISN strongly supported the goals and implementation of the 2030...

ISN heads to Copenhagen for WHO Regional Committee

ISN will attend the 66th session of World Health Organization (WHO) Regional Committee for Europe, taking place in Copenhagen as of September 12, 2016. ISN Advocacy advisor Dr. Valerie Luyckx will contribute to the current discussions on health on behalf of the nephrology community in the context of the 2030 Agenda for Sustainable Development and...

Kidney disease acknowledged as NCD at UN meeting

Recent ISN efforts to better position kidney disease on the global health agenda paid off recently as kidney disease was mentioned in the resolution stemming from the recent United Nations High Level Meeting on non-communicable diseases (NCDs). The document recognizes that: “renal, oral and eye diseases pose a major health burden for many countries and that these...

CKDu in Sri Lanka

Adeera Levin, Marcello Tonelli and David Harris represented ISN at a three-day workshop sponsored by the World Health Organization (WHO), which took place in April in Colombo and focused on the epidemic of chronic kidney disease of unknown etiology (CKDu). This is afflicting a large number of agricultural workers in Sri Lanka, particularly in...

CKDu in Sri Lanka’s population

On December 16, 2015, Georgi Abraham and I had the honor of being invited to discussions with Sri Lanka’s President Maithripala Sirisena, the country’s Minister of Health as well as the leadership of the Sri Lankan Society of Nephrology. We set out to address issues related to the epidemic of Chronic Kidney Disease of undetermined...

ISN position statement on CKDu

ISN has released a position statement on the epidemics of chronic kidney disease of uncertain aetiology (CKDu). CKDu has become a worldwide concern. ISN supports scientific and educational efforts to improve its outcome. ISN’s commitment to the care of people with kidney disease in all parts of the world is reflected in its concern about...

0by25 Initiative and Global Burden of Disease agree for AKI inclusion in 2014 report

The ISN is partnering with the Institute for Health Metrics and Evaluation to incorporate Acute Kidney Injury incidence data from the Initiative into the upcoming Global Burden of Disease (GBD) 2014 Study. The GBD Study is the world’s largest single source of leading contributors to health loss within society.  Incorporation of AKI into this study...

WHO Action plan 2013-2020

The UN High-Level Panel on the Post-2015 Development Agenda recently released its report (CLICK HERE), which identifies reducing the burden of non-communicable diseases (NCDs) as priority. The Lancet Series on Global Kidney Disease highlights the increasing burden of chronic kidney disease worldwide. The 2011 report of the WHO General Assembly on NCDs also identified chronic...